N-PORT filing recap · September 2021
What did Meridian Contrarian Fund buy in September 2021?
Reported stock-position changes between this filing and the previous one. These are Meridian Contrarian Fund's own holdings, not the firm's.
Stock value
$690.20M
Positions
73
Estimated turnover
20.6%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
New positions
TAPMolson Coors Beverage Co$8.72Mreported value+188.0K sharesFTDRFrontdoor, Inc.$8.30Mreported value+198.0K sharesPRPLPurple Innovation, Inc.$6.77Mreported value+322.0K sharesCRCCalifornia Resources Corp$5.33Mreported value+130.0K sharesCCJCameco Corporation$3.80Mreported value+175.0K sharesORICOric Pharmaceuticals, Inc.$509.7Kreported value+24.4K shares